| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14K | — | +0.0% |
| Cost of Revenue | $7K | — | +0.0% |
| Gross Profit | $7K | — | +0.0% |
| R&D Expense | $17.5M | -17.5% | -8.1% |
| SG&A Expense | $5.2M | +6.3% | +9.2% |
| Operating Income | -$22.7M | +13.0% | +4.6% |
| Net Income | -$45.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $77.7M | +248.4% | -8.3% |
| Inventory | $73K | — | +0.0% |
| Current Assets | $79.7M | +198.6% | -9.1% |
| Total Assets | $114.3M | +84.3% | -10.0% |
| Current Liabilities | $18.7M | -14.4% | +18.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$69.0M | — | — |
| Capital Expenditures | $554K | — | — |
| Investing Cash Flow | -$554K | — | — |
| Financing Cash Flow | $79.7M | — | — |
| Free Cash Flow | -$69.5M | — | — |
| -96.8% |
| EPS (Basic) | -$0.71 | -24.6% | -47.9% |
| EPS (Diluted) | -$0.71 | -24.6% | -47.9% |
| $117.5M |
| +46.4% |
| +53.3% |
| Stockholders' Equity | -$3.2M | +82.5% | -106.3% |